Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Pater

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Statistics in Medicine|July 15, 1994
Timing the collaborative analysis of three trials comparing 5-FU plus folinic acid (FUFA) to surgery alone in the management of resected colorectal cancer: a National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG) perspectiveJ L Pater
Statistics in Medicine|March 1, 1993
The use of data monitoring committees in Canadian trial groupsJ L Pater
Lancet (London, England)|September 18, 1993
Polychemotherapy in advanced non-small-cell lung cancerJ L Pater
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1983
Improvement in survival after recurrence of carcinoma of the breastJ L Pater, M Loeb
The New England Journal of Medicine|June 15, 1995
Antiemetic properties of granisetronJ L Pater, D Warr
Cancer|July 15, 1982
Nonanatomic prognostic factors in carcinoma of the lung: a multivariate analysisJ L Pater, M Loeb
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1986
Reporting the results of randomized trials of empiric antibiotics in febrile neutropenic patients--a critical surveyJ L Pater, L Weir
Controlled Clinical Trials|June 1, 1984
Clinical trials as diagnostic testsJ L Pater, A R Willan
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1988
The effect of different measures of outcome on the results of studies of empiric antibiotic therapy in febrile neutropenic patientsC R Elliott, J L Pater
Seminars in Oncology|February 1, 1992
Carboplatin in the treatment of carcinoma of the ovary: the National Cancer Institute of Canada experience. Ovarian Cancer SubcommitteeK D Swenerton, J L Pater
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Statistics in Medicine|July 15, 1994
Timing the collaborative analysis of three trials comparing 5-FU plus folinic acid (FUFA) to surgery alone in the management of resected colorectal cancer: a National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG) perspectiveJ L Pater
Statistics in Medicine|March 1, 1993
The use of data monitoring committees in Canadian trial groupsJ L Pater
Lancet (London, England)|September 18, 1993
Polychemotherapy in advanced non-small-cell lung cancerJ L Pater
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1983
Improvement in survival after recurrence of carcinoma of the breastJ L Pater, M Loeb
The New England Journal of Medicine|June 15, 1995
Antiemetic properties of granisetronJ L Pater, D Warr
Cancer|July 15, 1982
Nonanatomic prognostic factors in carcinoma of the lung: a multivariate analysisJ L Pater, M Loeb
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1986
Reporting the results of randomized trials of empiric antibiotics in febrile neutropenic patients--a critical surveyJ L Pater, L Weir
Controlled Clinical Trials|June 1, 1984
Clinical trials as diagnostic testsJ L Pater, A R Willan
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1988
The effect of different measures of outcome on the results of studies of empiric antibiotic therapy in febrile neutropenic patientsC R Elliott, J L Pater
Seminars in Oncology|February 1, 1992
Carboplatin in the treatment of carcinoma of the ovary: the National Cancer Institute of Canada experience. Ovarian Cancer SubcommitteeK D Swenerton, J L Pater
Pageof 7